HK1119244A1 - Detecting and predicting pre-eclampsia - Google Patents

Detecting and predicting pre-eclampsia

Info

Publication number
HK1119244A1
HK1119244A1 HK08112797.2A HK08112797A HK1119244A1 HK 1119244 A1 HK1119244 A1 HK 1119244A1 HK 08112797 A HK08112797 A HK 08112797A HK 1119244 A1 HK1119244 A1 HK 1119244A1
Authority
HK
Hong Kong
Prior art keywords
eclampsia
detecting
predicting
predicting pre
technology described
Prior art date
Application number
HK08112797.2A
Inventor
Lucilla Poston
Andrew Shennan
Original Assignee
Perkinelmer Las Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Perkinelmer Las Inc filed Critical Perkinelmer Las Inc
Publication of HK1119244A1 publication Critical patent/HK1119244A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/715—Assays involving receptors, cell surface antigens or cell surface determinants for cytokines; for lymphokines; for interferons
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Abstract

The technology described herein relates to methods of detecting or predicting pre-eclampsia (PE). The technology described herein also relates to commercial packages, such as diagnostic kits, for performing a method of detecting or predicting PE. In particular, the technology described herein provides methods of predicting pre-eclampsia when determining the levels of biochemical markers.
HK08112797.2A 2006-01-17 2008-11-21 Detecting and predicting pre-eclampsia HK1119244A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0600916.1A GB0600916D0 (en) 2006-01-17 2006-01-17 detecting and predicting pre-eclampsia
PCT/GB2007/000123 WO2007083099A1 (en) 2006-01-17 2007-01-17 Detecting and predicting pre-eclampsia

Publications (1)

Publication Number Publication Date
HK1119244A1 true HK1119244A1 (en) 2009-02-27

Family

ID=35998177

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08112797.2A HK1119244A1 (en) 2006-01-17 2008-11-21 Detecting and predicting pre-eclampsia

Country Status (11)

Country Link
US (1) US7638287B2 (en)
EP (1) EP1974220B1 (en)
JP (1) JP2009524014A (en)
AT (1) ATE504002T1 (en)
AU (1) AU2007206756B2 (en)
CA (1) CA2602681C (en)
DE (1) DE602007013524D1 (en)
ES (1) ES2364314T3 (en)
GB (1) GB0600916D0 (en)
HK (1) HK1119244A1 (en)
WO (1) WO2007083099A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2614832B1 (en) 2007-02-12 2016-07-13 A1M Pharma AB Diagnosis and treatment of preeclampsia
GB0715030D0 (en) * 2007-08-02 2007-09-12 Wilson Carol J Testing process
CN102216468B (en) * 2008-01-25 2014-06-11 珀金埃尔默健康科学股份有限公司 Methods for determining the risk of prenatal complications
AU2009316392B2 (en) * 2008-11-20 2015-05-21 Perkinelmer Health Sciences, Inc. Method for determining the risk of preeclampsia using PIGF-2 and PIGF-3 markers
CA2751679C (en) 2009-02-06 2018-02-27 Women & Infants' Hospital Of Rhode Island Compositions for treating preeclampsia-type disorders of pregnancy comprising transthyretin
US20130122529A1 (en) * 2010-03-24 2013-05-16 Preelumina Diagnostics Ab HbF AND A1M AS EARLY STAGE MARKERS FOR PREECLAMPSIA
CN104136924B (en) * 2011-12-15 2018-05-29 麦卡蒂斯股份有限公司 For the biomarker and parameter of pre-eclampsia
WO2013163318A1 (en) * 2012-04-24 2013-10-31 Siemens Healthcare Diagnostics, Inc. Pre-eclampsia screening methods
WO2014124396A1 (en) 2013-02-08 2014-08-14 University Of Iowa Research Foundation Therapeutic strategies for the treatment of preeclampsia
US10119978B2 (en) 2013-03-15 2018-11-06 Wallac Oy System and method for determining risk of diabetes based on biochemical marker analysis
PL3189336T3 (en) 2014-09-02 2019-07-31 Wallac Oy Method for determining risk of pre-eclampsia
US20200395127A1 (en) * 2017-11-17 2020-12-17 University Of Washington Connected system for information-enhanced test results
EP4070113A4 (en) 2019-12-04 2023-12-20 Biora Therapeutics, Inc. Assessment of preeclampsia using assays for free and dissociated placental growth factor
GB2620035A (en) * 2021-02-10 2023-12-27 Mirvie Inc Methods and systems for conducting pregnancy-related clinical trials

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2275708A1 (en) 1996-12-23 1998-07-02 Cambridge University Technical Services Limited Diagnosis and treatment of pathological pregnancies
GB0026823D0 (en) 2000-11-02 2000-12-20 King S College London Diagnosis of pre-eclampsia
US7435419B2 (en) * 2002-07-19 2008-10-14 Beth Israel Deaconess Medical Center Methods of diagnosing and treating pre-eclampsia or eclampsia
GB0308967D0 (en) * 2003-04-17 2003-05-28 Univ London Screen for pre-eclampsia
WO2005031364A1 (en) * 2003-09-23 2005-04-07 The General Hospital Corporation Screening for gestational disorders
CA2485722A1 (en) * 2003-10-22 2005-04-22 Paul Lehmann Soluble transferrin receptor

Also Published As

Publication number Publication date
CA2602681A1 (en) 2007-07-26
US20070178530A1 (en) 2007-08-02
JP2009524014A (en) 2009-06-25
AU2007206756A1 (en) 2007-07-26
ES2364314T8 (en) 2011-09-22
WO2007083099A1 (en) 2007-07-26
CA2602681C (en) 2017-03-14
US7638287B2 (en) 2009-12-29
ES2364314T3 (en) 2011-08-31
EP1974220B1 (en) 2011-03-30
EP1974220A1 (en) 2008-10-01
ATE504002T1 (en) 2011-04-15
GB0600916D0 (en) 2006-02-22
AU2007206756B2 (en) 2011-06-16
DE602007013524D1 (en) 2011-05-12

Similar Documents

Publication Publication Date Title
GB0600916D0 (en) detecting and predicting pre-eclampsia
WO2012021795A3 (en) Pancreatic cancer biomarkers and uses thereof
WO2009048530A3 (en) Highly multiplexed particle-based assays
WO2010129934A3 (en) Methods and compositions for diagnosis of thyroid conditions
WO2008061104A3 (en) Methods and kits for detecting prostate cancer biomarkers
WO2009129505A3 (en) Compositions, methods, and kits using synthetic probes for determining the presence of a target nucleic acid
WO2007100506A3 (en) Mass tags for quantitative analyses
NZ605698A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2012037937A3 (en) Method for detecting, differentiating, and quantifying t cell populations by means of reverse transcription quantitative real-time pcr (rt-qpcr) technology
WO2010075360A3 (en) Methods for detection of sepsis
WO2010092164A3 (en) Bacterial dna as markers of cardiovascular and/or metabolic disease
WO2011142781A3 (en) Pore-limit electrophoresis (ple) microchannel assays
MX2009010751A (en) Compositions and methods of detection.
ATE500503T1 (en) CD86 AND CD80 RECEPTOR COMPETITION TESTS
DK2118666T3 (en) Method of normalizing the concentration of analytes in a urine sample
MX2009004852A (en) Method for determining dna fragmentation in microorganisms.
WO2008034622A3 (en) A method of detecting and/or quantifying expression of a target protein candidate in a cell, and a method of identifying a target protein of a small molecule modulator
TW200745551A (en) Device and methods for detecting and quantifying one or more target agents
WO2009092982A3 (en) Method for detecting and/or identifying clostridium difficile
AU2006254891A8 (en) Compositions, methods and kits for determining the presence of Chlamydophila pneumoniae in a test sample
WO2006099537A3 (en) The use of antibody-surrogate antigen systems for detection of analytes
WO2009007649A3 (en) Device and method for identifying and determining blood groups
WO2009126889A8 (en) Assays for detecting pregnancy-associated glycoproteins
WO2005028621A3 (en) Assays with primary cells
WO2010096594A3 (en) Method for identifying a subpopulation of mammalian cells with distinctive ribosome translation profiles